NCT07901114
A Bioequivalence and Safety Study of AJU-C719 and C719R in Healthy Adult Volunteers
Track this trial
Free. We email you which fields changed when ClinicalTrials.gov updates this record.
Record History
All 1 version: 1 with changes below.
- Study First Submitted
Endpoints
Primary
AUCt of AJU-C719
Timeframe: Pre-dose(0 hours) ~ 72 hours
Cmax of AJU-C719
Timeframe: Pre-dose(0 hours) ~ 72 hours
Secondary (4)
AUCinf of AJU-C719
Tmax of AJU-C719
t1/2 of AJU-C719
AUCt/AUCinf of AJU-C719
Arms and interventions
Sequence AExperimental
Period 1: Reference Drug, Single dose / Period 2: Test Drug, Single dose
Sequence BExperimental
Period 1: Test Drug, Single dose / Period 2: Reference Drug, Single dose
Drugs: Test Drug, Reference Drug
Sites
1 site in 1 country
- Bumin Hospital (Seoul)Seoul, Seoul, South Korea